Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study

doi:10.5306/wjco.v11.i6.397

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6874)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

212

WORD

HTML

3860

Figures (1-2)

246

Tables (1-3)

229

Sum=4613

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

665

Download

1596

Sum=2261

Jun 24, 2020 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Oncol. Jun 24, 2020; 11(6): 397-404
Published online Jun 24, 2020. doi: 10.5306/wjco.v11.i6.397

Table 2 Immunological analysis: absolute values, cells/L

		Baseline						30 d after HIPEC
ID	Tumor type	CD3⁺	CD3⁺/CD4⁺ T helpe r	CD3⁺/CD8⁺ T cytotoxic	CD3^-/CD56⁺ NK	CD19+ B lymphocytes	CD4/CD8 ratio	CD3⁺	CD3⁺/CD4⁺ T helper	CD3⁺/CD8⁺ T cytotoxic	CD3^-/CD56⁺ NK	CD19+ B lymphocytes	CD4/CD8ratio
1	Colon	842	602	188	234	61	3	1335	835	409	501	78	2
2	PMP	970	505	473	238	129	1	487	300	187	57	68	2
3	PMP	1044	1500	1700	475	150	1	4477	2248	2179	576	488	1
4	Colon	1244	1075	158	44	230	7	1409	1095	290	116	148	4
5	PMP	1228	874	340	141	134	3	2304	1443	846	421	141	2
6	PMP	912	776	147	173	152	5	2002	1184	782	334	184	2

PMP: Pseudomyxoma peritonei; HIPEC: Hyperthermic intraperitoneal chemotherapy; NK: Natural killer.

Citation: Fiorentini G, Sarti D, Patriti A, Eugeni E, Guerra F, Masedu F, Mackay AR, Guadagni S. Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study. World J Clin Oncol 2020; 11(6): 397-404
URL: https://www.wjgnet.com/2218-4333/full/v11/i6/397.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i6.397